The nucleoside and nucleotide mixture (OG-VI) rescues intestinal-like epithelial cells from the cytotoxicity of chemotherapeutic agents

J Med Invest. 2007 Aug;54(3-4):235-42. doi: 10.2152/jmi.54.235.

Abstract

Immune cells and cells undergoing rapid turn-over can obtain exogenous nucleotides via salvage synthesis. We evaluated whether or not the balanced nucleoside and nucleotide mixture OG-VI, could rescue intestinal epithelial-like Caco-2 cells from the cytotoxic effects of several chemotherapeutic agents, in the presence and absence of glutamine (Gln). Cells were exposed to 5-fluorouracil (5FU), methotrexate (MTX) or 6-mercaptopurine (6MP), after which proliferation and cell cycle analyses were performed. Following exposure to the chemotherapeutic agents, we observed that cells treated with OG-VI proliferated well, whereas those without the supplement did not proliferate. Furthermore, following treatment with either 5FU or MTX, we observed that the number of cells in the G0/G1 phase decreased and those in the S phases increased. However, these cell cycle alterations were prevented by the addition of OG-VI. With the exception of 6MP-treated cells, we did not observe any effects on proliferation or cell cycle regulation that could be ascribed to the presence of Gln. Thus, we have demonstrated that OG-VI rescues cells from the cytotoxic effects of several chemotherapeutic agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / toxicity*
  • Caco-2 Cells
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Fluorouracil / toxicity
  • Humans
  • Intestines / cytology
  • Intestines / drug effects*
  • Mercaptopurine / toxicity
  • Methotrexate / toxicity
  • Nucleosides / pharmacology*
  • Nucleotides / pharmacology*

Substances

  • Antineoplastic Agents
  • Nucleosides
  • Nucleotides
  • OG-VI solution
  • Mercaptopurine
  • Fluorouracil
  • Methotrexate